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cell mates

David Bodine enlists Colby researchers in a bid
to unlock the genetic mysteries of blood disorders

By Steve Heacock
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Tucked away in glass-sheathed Building 49 on the sprawling 300-acre home
campus of the National Institutes of Health, in Bethesda, Maryland, David Bodine
’76 stalks the halls—examining slides, studying results, and exhorting his colleagues as they divine the mysteries of blood cells.
Bodine is rangy and fit; it’s apparent that he has kept up his running (he ran
track and cross country at Colby). Don’t expect a white lab coat. If you see him
at work, he will likely be wearing Nike running shoes, baggy gray sweats, and a
faded tennis shirt. “As you probably noticed,” said one colleague at the National
Human Genome Research Institute (NHGRI) with a wry smile, “fashion is very
important to Dave.”
What is important to Bodine is the diligence and the professional collegiality of his “section”—his laboratory. Bodine’s team is figuring out why blood cell
development doesn’t always work properly—and how to fix it when it goes wrong.
The team’s focus is a group of diverse inherited blood diseases (most are anemias)
having to do with faulty or reduced production of red blood cells that develop
from stem cells in bone marrow. Red cells contain hemoglobin, the essential protein that carries oxygen to the cells of the body. He is clearly energized by his
work and by the science going on around him, and he is eager to mentor young
scientists—many of whom are from Colby.
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“Very broadly, we’re talking about red cells that are
arresting their maturation just short of being good red
blood cells,” Bodine said one blustery November day, as
windswept rain lashed Building 49. “We are learning how
to regulate red cell production in animals. Gene therapy? Someday,
I hope. But a drug that would do an end run around invasive gene
therapy would be just as desirable. Our job is to come up with the
targets, understand why the cells work and don’t work, and determine what is correctable.”
One of the curious aspects of some of these blood disorders is
their propensity to afflict certain populations. Some African, Asian,
and Mediterranean populations are more prone than others to hereditary blood diseases like thalassemia and other anemias. Approximately 100,000 babies are born worldwide every year with severe
forms of thalassemia, which most often limit life expectancy to between 20 and 30 years but also can cause death in newborns. Genetic
evidence suggests that in Sicily, for example, 6 to 12 percent of the
population could transmit thalassemia to their children.
“Some of the broader questions,” Bodine said, “are why are there
so many people with this disease gene in these particular geographical areas? And why doesn’t natural selection make it go away?” In the
case of thalassemia, the affected red blood cells provide a poor host
for the parasite that causes malaria, which is endemic to these parts
of the world, so it is an evolutionary tradeoff.
Pilon’s work focuses on gene regulation, figuring out which genetic
“pathways” are wrong in defective red blood cells. He studies mice that
are missing a key protein called a transcription factor. He analyzes red
blood cell maturation in these mice to determine why the hematopoietic cells do not generate the proper number and quality of red cells.
He has discovered that these cells
do not divide correctly and cannot
mature (or differentiate) into the
cells they need to become.
“My work is to find out the
molecular biology that lies under all of that,” Pilon said. “The
DNA is the genetic material or
code in the cells. RNA is the message that tells the cell to make the
transcription factor that, in turn,
triggers production of other proteins needed for cell division.
Certain genes are ‘turned on’
when this process happens, and
I’m trying to figure out why they
aren’t turned on in these defective cells. I have to see how the
transcription factor causes a gene
to be activated or repressed.”
Pilon has been in the Ph.D.
program at George Washington
University since 2004, part of the
NIH Graduate Partnerships Program. At Colby he worked in the
David Bodine ’76, center, confers with researchers Serena Vayda ’03, left, and André Pilon ’03 at the National
research laboratory of Julie MilInstitutes of Health’s Genetics and Molecular Biology Branch laboratory. Vayda and Pilon are members of
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on’t let the sweatpants fool you. Bodine is a
leader in his field, and his research could lead to
groundbreaking ways to treat serious blood disorders.
Next year will be Bodine’s 23rd at the NIH, where he recently
was named chief of the Genetics and Molecular Biology Branch.
The promotion last fall is the latest in an accomplished career that
began in 1984 at the NIH’s Clinical Hematology Branch of the National Heart, Lung, and Blood Institute. As a senior staff fellow, he
launched his own lab in 1988, and five years later he was recruited to
the NHGRI’s Hematopoiesis Section of the Genetics and Molecular
Biology Branch. He received tenure in 1995. He has won a slew of
awards, including the NIH National Research Service Award and
the NHGRI Mentor of the Year Award.
This is no small thing, coming from one of the largest and most
esteemed centers of biomedical research in the world, an organization that employs more than 19,000 people. The NHGRI alone employs 750. Bodine’s branch consists of approximately 60 researchers
and scientists, and his lab is made up of a dozen scientists.
He clearly has put his stamp on his lab.
“He has this saying, every day,” said André Pilon ’03, one of a long
line of Colby students and graduates who have gone to work with
Bodine. “He walks in every morning and asks us, ‘What are you doing to thrust back the boundaries of ignorance today?’”
It appears that Bodine and his colleagues are doing plenty.
They are hard at work studying the genetic underpinnings of hematopoiesis, the process of blood formation. Hematopoietic stem
cells, found in bone marrow, turn into red blood cells and the many
different types of white blood cells. Anemia, leukemia, and a variety
of other blood diseases disrupt the process.

Bodine’s team, which investigates causes of red blood cell disorders.
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lard, the Dr. Gerald and Myra Dorros Professor of Life Sciences and
chair of Chemistry, and discovered that the biochemistry program
was a feeder for Bodine’s NIH lab. Once Pilon started working for
Bodine, he recruited one of his Colby classmates, Serena Vayda ’03.
On the face of it, Vayda, a biology major with an environmental science concentration, was perhaps not an obvious natural fit for
Bodine’s lab. But she has flourished. Working in the Flow Cytometry Core Facility, her work is highly specific and technical. Using
flow cytometry, Vayda can analyze single cells, determine their size,
and analyze proteins on the cell surfaces. The flow cytometer scans
10,000 cells per second. “We’re trying to come up with a new way to
correct defective cells, and that could mean gene therapy,” she said.
“You could introduce a therapeutic gene into a cell using a virus.
But you have to know just what cells you have targeted. Eventually, a
corrected non-stem cell just dies, but a corrected stem cell will keep
making blood cells forever.”
Vayda plans to enter medical school next fall, perhaps to pursue
hematology.
The Colby-Bodine connection has also benefited Emily Devlin
’07, a Colby senior from Pennington, N.J., who managed to spend
eight months in Bodine’s lab. She worked with the Biology Department to turn her Washington Semester into NIH lab work, tacking
Jan Plan on the front end of that semester and a summer internship on the back end. She plans to return after graduation, work in
Bodine’s lab again, and eventually enter an M.D./Ph.D. program.
Supervised closely by Bodine, Devlin was given two projects to
work on by herself. “That was really fun,” she said. “He is involved
with everyone in that lab. He is constantly educating everyone. He
trained me and taught me a tremendous amount.” One project Devlin worked on was generating a mouse model for a rare blood disease,
Diamond Blackfan Anemia. This is the project she will return to
later this year. Devlin’s other project focused on DNA regulatory
elements in the beta-globin gene clusters. Her father, with a Ph.D.
in toxicology, and her mother, an engineer, were enthusiastic about
Devlin’s NIH opportunity.
Pilon and Devlin, with encouragement and guidance from Bodine,
traveled to Orlando in December to present at the 48th annual meeting of the American Society of Hematology. Both researchers gave
10-minute talks in front of approximately 200 people. Their work
had been chosen from nearly 7,000 submissions for about 875 oral
presentations. Word got back to Bodine, he said, that Pilon and Devlin were the most polished and poised presenters in their sessions.
“It impresses me that Colby trains these students in a certain
way,” he said. “The hands-on approach is really there in Julie Millard’s lab. We have students and graduates from other schools here,
too, of course. But the Colby kids start so much faster. The day they
get here they are doing the science. The others are great, too, but
they have to ramp up. The Colby kids come here knowing how to
keep a notebook, organize their time, and keep data.”
Pilon agreed. “The amount of research and hands-on science is
really rigorous [at Colby],” he said. “Even in the first years, you’re not
just staring down the barrel of a microscope sketching pictures of cell
structures. You’re doing real science and learning important techniques in the lab courses. And then you move on to Julie Millard and
it’s a research-mentor relationship. … Then to get the opportunity to

the colby—nih pipeline
Professor Julie Millard, the Dr. Gerald and Myra Dorros
Professor of Life Sciences and chair of the Chemistry Department,
and her colleagues know “Bodine material” when they see it. But
the honor, which goes to especially promising, budding scientists,
carries an admonition.
“I tell each one before they go to Bethesda,” Millard said,
“‘Don’t mess it up for the next one.’”
It seems to be working. André Pilon ’03, in the Ph.D. program at
George Washington University and currently working with Bodine in
the lab, says it’s obvious that people are “coming here for a reason.
Dave has a genuine interest in us doing well.”
“He knows research and good academic training are the
building blocks,” said Whitney King, the Dr. Frank and Theodora
Miselis Professor of Chemistry and associate chair of the
department. “On the reaccreditation committee, we are looking at
outcomes, and in the sciences he was a logical person to talk to.
Dave gave us very high marks and helps us with external reviews
of all kinds. He is helping us become a better institution as an
outside evaluator. His professional credibility is just tremendous.
The unspoken qualification to get into grad school is research.
It’s not required, but it’s a qualification. Dave’s mentoring and
encouragement go a long way in helping us step up in that area.”
Millard, now in her 16th year at Colby, stresses undergraduate
research as an integral part of the Colby chemistry experience.
“Working in a lab and presenting at a conference or meeting
are goals for us here,” she said. “We’ve provided research
opportunities for as long as anyone can remember. And David
Bodine has been extremely helpful. He came up to do a chemistry
seminar, the Howard Hughes Medical Institute grant overseers
invited him as an outside expert—he’s just been a great resource.
When we were starting to do work with cells, he sent us a
whole line of cells and all the media we needed. If I recommend
someone, he takes them. He’s just brilliant at letting them
blossom there. They all come back with rave reviews about the
lab—and they all love David Bodine.”

nih/colby alumni
Laurie Girard Eidt ’93: Graduate of Washington University, Physical Therapist,
Stamford, Conn.
Stephanie Andriole ’98: Graduate of Sarah Lawrence College, Genetic Counselor,
New York City
Claire Overgaag ’98: Graduate of Massachusetts General Hospital Institute for
Health Professionals, Nurse Practitioner, San Francisco area
Douglas Nilson ’99: Graduate of Northwestern Medical School, Emergency
Medicine, Providence, Rhode Island
Tiffany Frazar ’01: Graduate of University of Vermont Medical School, Resident
in Pediatrics, Boston, Mass.
Lindsey Rowland ’01: Graduate of St. George’s University School of
Veterinary Medicine
Jessica Weisbein ’01: Graduate of University of Pennsylvania Medical School
André Pilon ’03: Currently serving in NIH lab
Serena Vayda ’03: Currently serving in NIH lab
Nicholas Markham ’04: Attending Vanderbilt Medical School, M.D./Ph.D. Program
Erin Parry ’06: Attending the Johns Hopkins School of Medicine, M.D./Ph.D. Program
Emily Devlin ’07: Currently at Colby, slated to return to NIH lab
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work with Dave here and go to Orlando, where we can
hit up the big names in hematology, the ones who write
the books. It gives us a chance to give our talks, maybe attract the attention of someone whose lab we might want to visit. It
gives us a chance to line up our post-doc experience.”

B
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efore Millard and her colleagues Frank Fekete and Judy Stone
from the Biology Department started sending students to
Bodine, there was Professor Art Champlin. Champlin, who
passed away unexpectedly in 2003, taught Bodine at Colby in the
early ’70s. And it was Champlin, along with a fellow biology professor, the late Miriam Bennett, who mentored Bodine and gave him
the support and encouragement he needed to thrive. “I never can repay them for the time and trouble they took with me,” said Bodine.
Bodine double majored (biology and environmental studies) and
graduated cum laude with distinction in both. He also won the Webster Chester Biology Award. Bodine earned his master’s in human
genetics at Rutgers and his Ph.D. in zoology and genetics at the University of Maine, followed by research at the Jackson Laboratory in
Bar Harbor. In between his course work at Orono and the beginning
of his research at the Jackson Lab, Bodine returned to Waterville,
living briefly with Champlin and his wife, Betsy ’65 (now Betsy Stark
Roberts, who returned in 1971 to work in the Biology Department
for 33 years).
Bodine volunteered to work in the Biology Department and,
in his spare time, built a garden for the Champlins; the garden
was still intact when Roberts sold the house in 2005. His interest in gardening continues. When spring bulbs are blooming at
his Chevy Chase, Maryland, home (where he lives with his wife,
Susan, a lawyer and assistant administrator in the EPA’s Office of
Solid Waste and Emergency Response, and their two sons, Christopher and Steven), Roberts is sure to find out by e-mail. Living

David Bodine ’76 at the National Institutes of Health in Bethesda, Maryland.
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inside the Beltway and gardening in Hardiness Zone 6
haven’t turned Bodine into an Orioles or a Nationals
fan, though: his NIH e-mail handle remains tedyaz—
for Red Sox legends Ted Williams and Carl Yastrzemski.
Bodine received his Ph.D. in 1984 and did his post-doctoral and
staff fellowships at the NIH’s Clinical Hematology Branch of the
National Heart, Lung, and Blood Institute in Bethesda. And, as his
career has progressed, he’s focused some of his considerable energy
on Colby.
“He is very devoted to Colby and to Colby students,” Roberts
said. “He thinks of that as a very important part of his work and he’s
always looking for more. He would write to Art, to me, asking what
we thought about certain students at Colby. I think it goes back to
the mentoring he got while he was a student at Colby. He is dedicated to providing it to other Colby students.”
He also is dedicated to his profession, and that means publishing
at the highest level and taking leadership roles in professional societies. He has long held leadership positions in the American Society
of Hematology, the International Society of Experimental Hematology, the Leukemia and Lymphoma Society, and the American Society of Gene Therapy, where he will serve as president beginning
in 2008. He has been published widely throughout his career and
has served on the editorial boards of Experimental Hematology, Gene
Therapy, the British Journal of Hematology, Molecular Therapy, and
Blood, the official journal of the American Society of Hematology
and the most-cited peer-reviewed journal in the field.
His curriculum vitae runs more than 25 pages.
But throughout his distinguished career, one of Bodine’s experiences at the Jackson Laboratory has stayed with him—and speaks to
the essence of his love for his work.
“One Saturday morning I was doing an experiment that everyone thought was dumb,” he said. “I had a good hypothesis, though,
and I really believed in that experiment. It required forty or
fifty vials that had to be analyzed
individually by a scintillation
counter. I remember waiting by
the counter so that I could see
each value as it was recorded. I
could have gone away and come
back for the printout at the end of
the analysis, but I was so excited
to see the result, I could not wait.
If anyone had seen me, they’d
have thought I was nuts. But, I
thought, ‘I’m the only one in the
world doing this and I can’t wait
to see the results. This must be
the right place for me.’”

